NMac1
(Synonyms: Nm23 activator 1) 目录号 : GC27368NMac1 (Nm23 activator 1) 是一种天然产物 cassumunene,从姜科植物 Zingiber cassumunar Roxb.中提取,在东亚传统上用作抗炎剂。
Cas No.:1332290-68-2
Sample solution is provided at 25 µL, 10mM.
NMac1 (Nm23 activator 1) is a natural compound, cassumunene, derived from Zingiber cassumunar Roxb. and traditionally used as an anti-inflammatory agent in East Asia. NMac1 exhibits anti-metastatic potential by directly interacting with the C-terminal of Nm23-H1, activating its NDP kinase (NDPK) enzymatic activity in vitro. NMac1 inhibits breast cancer metastasis in vivo.
In vitro, NMac1 is a potent activator of NDPK protein, activating NDPK activity of recombinant Nm23-H1 in a dose-dependent manner with an EC50 of 10.7 μM.
The morphological changes observed in MDA-MB-231 cells after treatment with NMac1 (25 μM) included substantial changes in the original height mesenchymal type (with a large number of folds) to a non-metastatic form with reduced folds and increased cell coverage.
NMac1 significantly reduced invasion and migration of MDA-MB-231 cells in a dose-dependent manner without affecting their proliferation. [1]
In vivo, In NOD/SCID mice injected in situ with MDA-MB-231-LUS-D3H2LN cells, treatment with NMac1 (10 mg/Kg, 3 weeks) significantly inhibited breast cancer metastasis without affecting primary tumor size. [1]
References:
[1]. Lee JJ, et al. Small molecule activator of Nm23/NDPK as an inhibitor of metastasis. Sci Rep. 2018 Jul 19;8(1):10909.
[2]. Kim, B., Lee, JJ., Shin, J.S. et al. Nm23-H1 activator phenylbutenoid dimer exerts cytotoxic effects on metastatic breast cancer cells by inducing mitochondrial dysfunction only under glucose starvation. Sci Rep 11, 23549 (2021).
NMac1 (Nm23 activator 1) 是一种天然产物 cassumunene,从姜科植物 Zingiber cassumunar Roxb.中提取,在东亚传统上用作抗炎剂。NMac1 通过与 Nm23-H1 的 C 端直接相互作用,在体外激活其 NDP 激酶(NDPK)酶活性,具有抗转移潜力,并在体内实验中抑制乳腺癌转移。
在体外,NMac1 是 NDPK 蛋白的有效激活剂,以剂量依赖性方式激活重组 Nm23-H1 的 NDPK 活性,EC50 为 10.7 μM。
NMac1(25 μM) 处理后在 MDA-MB-231 细胞中观察到的形态变化包括原始高度间充质型(具有大量褶皱)的实质性改变,转变为具有减少褶皱和细胞覆盖面积增加的非转移性形态。
NMac1 以剂量依赖性方式显着降低 MDA-MB-231 细胞的侵袭和迁移,而不影响其增殖。[1]
在体内,在原位注射 MDA-MB-231-Luc-D3H2LN 细胞 NOD/SCID 小鼠中,NMac1(10 mg/Kg,3周)处理可以显著抑制乳腺癌转移,而不影响原发肿瘤大小。[1]
| Cas No. | 1332290-68-2 | SDF | |
| 别名 | Nm23 activator 1 | ||
| Canonical SMILES | C(=C/C1=CC(OC)=C(OC)C=C1)\C2C(C=CCC2)C3=CC(OC)=C(OC)C=C3 | ||
| 分子式 | C24H28O4 | 分子量 | 380.48 |
| 溶解度 | 储存条件 | -20°C | |
| Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.6283 mL | 13.1413 mL | 26.2826 mL |
| 5 mM | 525.7 μL | 2.6283 mL | 5.2565 mL |
| 10 mM | 262.8 μL | 1.3141 mL | 2.6283 mL |
| 第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
| 给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
| 第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
















